These findings indicate that SNHG1 functions as a significant oncogene in BC, with its aberrant expression leading to the development and progression of BMIBC, and are in line with the present study that ISO treatment induces a decrease in SNHG1 transcription levels, leading to significantly reduced invasion and anchorage-independent growth of BMIBC cells. This evidence concerns the gene SNHG1 and breast cancer.